Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023


Market Highlights:
The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis.
Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation proteomics workflows.  However, reduced funding in key markets of proteomics, high cost of tools & equipment and lack of skilled researchers can restrain the market growth over the assessment period.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6930

Key Players:
Some of the prominent players in the global proteomics market are
·         GENERAL ELECTRIC COMPANY
·         Bio-Rad Laboratories
·         Danaher
·         Siemens Ltd
·         Thermo Fisher Scientific Inc
·         Agilent Technologies
·         Genzyme Corporation
·         Biognosys AG
·         Bruker
·         Luminex Corporation
·         Merck KGaA
·         PerkinElmer Inc
·         WATERS
·         Caprion Biosciences Inc

Segmentation:
·         The global proteomics market has been segmented into equipment, services and application.
·         The market, on the basis of equipment, has been segmented into chromatography, mass spectroscopy, protein microarray, X-ray crystallography, protein fractionation and others.
·         The global market, on the basis of services, has been segmented into laboratory services and data analysis & services.
·         The global proteomics market, by application, has been segmented into drug discovery, clinical diagnosis and others. The clinical diagnosis segment is expected to hold the largest market share owing to the increased understanding of the relevance of investigating and understanding patterns of protein expression for diseases & drug development. The drug discovery segment is anticipated to grow at the fastest CAGR owing to continuous search for alternative & efficient methods to deliver enhanced drugs and increased R&D investments by pharmaceutical & biotechnology companies.

Regional Analysis:
Geographically, the Americas is expected to dominate the global market owing to the easy availability of funds from various organizations and rising interest in personalized medicines. According to the Personalized Medicine Coalition, number of available personalized medicines increased to 113 in 2014 from 13 in 2006. Europe is expected to hold the second largest position in the global market owing to the rising cancer research activities and high funding from the government. Asia-Pacific is expected to be the fastest growing market owing to the high prevalence of cancer and rising healthcare expenditure. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.

Access Full Report Details and Full TOC @ https://www.marketresearchfuture.com/reports/proteomics-market-6930

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

  1. SantaMedical4 July 2019 at 02:54

    Normal blood oxygen levels in humans are considered 95–100 percent. If the level is below 90 percent, it is considered low resulting in hypoxemia. Blood oxygen levels below 80 percent may compromise organ function, such as the brain and heart, and should be promptly addressed. check your Pulse Oximeter

    ReplyDelete
  2. alvinrabin27 August 2019 at 03:25

    It's a very informative study about Proteomics . It's useful in Surgical Sutures guidelines.

    ReplyDelete
  3. Universal Sutures8 September 2019 at 21:27

    That proteomics market report is very informative. That helpful for Surgical Sutures research.

    ReplyDelete
  4. Anonymous22 July 2022 at 04:53

    Thanks for your valuable post, Really nice and very informative.
    https://kingpure.in/product-category/premium-series/

    ReplyDelete

Post a Comment

Popular posts from this blog

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for
Read more